Amgen Issues Epogen and Procrit Recall - - BioPharm International


Amgen Issues Epogen and Procrit Recall

Today, Amgen issued a voluntary recall of 201 lots of Epogen and 155 lots of Procrit (epoitin alfa) because of concern about very thin glass flakes in the vials. The flakes, or lamellae, result from the interaction of the formulation with the glass vials over the shelf life of the product.

The company has announced that according to evaluations conducted by Amgen and Centocor, the risk to patients who have received product included in the recall is low. To date, there have been no complaints or adverse events reported which can be directly attributed to the presence of glass lamellae.  

Epogen and Procrit are both manufactured by Amgen. Epogen is sold by Amgen in the United States.  Centocor Ortho Biotech Products is the authorized distributor of Procrit in the United States.

Lists of the recalled product lots and expiration are available at at and

blog comments powered by Disqus



Suppliers Seek to Boost Single-Use Technology
August 21, 2014
Bristol-Myers Squibb and Celgene Collaborate on Immunotherapy and Chemotherapy Combination Regimen
August 20, 2014
USP Center in Ghana Receives International Lab Accreditation
August 15, 2014
USP Awards Analytical Research
August 15, 2014
FDA Warns about Fraudulent Ebola Treatments
August 15, 2014
Author Guidelines

Click here